Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06TJJ
|
|||
Former ID |
DNC013608
|
|||
Drug Name |
FLUORESCEIN
|
|||
Synonyms |
Ful-Glo; Fluoreseptic; 41935-48-2; NSC5070
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Ocular disease [ICD-11: 1F00.1Z] | Approved | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H12O5
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O
|
|||
InChI |
1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H
|
|||
InChIKey |
GNBHRKFJIUUOQI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 2321-07-5
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:31624
|
|||
ADReCS Drug ID | BADD_D00926 | |||
SuperDrug ATC ID |
S01JA01
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Mothers against decapentaplegic homolog 3 (SMAD3) | Target Info | Inhibitor | [2] |
Solute carrier family 22 member 8 (SLC22A8) | Target Info | Inhibitor | [3] | |
Pathwhiz Pathway | Kidney Function |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. | |||
REF 3 | Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem. 2007 Aug 17;282(33):23841-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.